HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Division of Orthopaedic Surgery News & Announcements
1 - 10 of 22
Published on Jul 22, 2022 in Cornerstone Blog
Learn about novel findings from our Children’s Hospital of Philadelphia researchers.
Published on Jan 31, 2022 in Cornerstone Blog
Identified by CHOP researchers, palovarotene is the first drug approved (in Canada) for fibrodysplasia ossificans progressiva, a severe bone disease.
Published on Jan 26, 2022 in Press Releases
Palovarotene is the first approved drug against fibrodysplasia ossificans progressiva (FOP), a rare and often fatal disease.
Published on Jul 23, 2021 in Cornerstone Blog
This week’s In the News features new study on measuring vision changes in patients with neurofibromatosis type 1, and other research highlights.
Published on Jul 7, 2021 in Press Releases
CHOP researchers identified the drug, palovarotene, to treat fibrodysplasia ossificans progressive (FOP).
Published on Jun 14, 2021 in Cornerstone Blog
CHOP and its individual departments ranked high in U.S. News and World Report’s Best Children’s Hospitals for 2021-2022.
Published on Feb 3, 2021 in Cornerstone Blog
The February Featured Research Trainee, Kaylia Duncan, reflects on Black History Month and her scientific career.
Published on Jun 19, 2020 in Cornerstone Blog
Study shows deep decline in number of pediatric patients visiting the emergency department for asthma treatment during first month of COVID-19 pandemic. This and more In the News.
Published on Jun 16, 2020 in Cornerstone Blog
U.S. News &World Report once again ranked CHOP as one of the top children’s hospitals in the United States
Published on Jun 5, 2020 in Cornerstone Blog
CHOP stays on top of COVID-19 research, from multisystem inflammatory syndrome in children to social distancing’s impact on fractures.